Pure sensory neuropathy in patients with primary Sjogren's syndrome: clinical, immunological and electromyographic findings by Font Franco, Josep, 1953-2006 et al.
Annals ofthe Rheumatic Diseases 1990; 49: 775-778
Pure sensory neuropathy in patients with primary
Sjogren's syndrome: clinical, immunological, and
electromyographic findings
J Font, J Valls, R Cervera, A Pou, M Ingelmo, F Graus
Abstract
A pure sensory neuropathy caused by lympho-
cytic infiltration of the dorsal root ganglia has
been reported in a few patients with Sjogren's
syndrome. The clinical, immunological, and
electromyographic findings of five patients
with this type of neuropathy and primary
Sj6gren's syndrome were reviewed. Typical
clinical indications were the presence of a
chronic asymmetrical sensory deficit, initial
disease in the hands with a predominant loss
of the vibratory and joint position senses, and
an association with Adie's pupil syndrome or
trigeminal sensory neuropathy. The simul-
taneous impairment of the central and peri-
pheral evoked cortical potentials suggested
that there was a lesion of the neuronal cell
body. The neuropathy preceded the diagnosis
of Sj6gren's syndrome in four patients. Four
patients were positive for Ro antibodies, but
systemic vasculitis or malignancy was not
found after a mean follow up of six years.
These findings indicate that in patients with a
sensory neuropathy the diagnosis of Sj6gren's
syndrome has to be considered, even if the
patient denies the presence ofsicca symptoms,
and that appropriate tests must be carried out.
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Sjogren's syndrome is a chronic, multisystem
immunological disorder that is characterised by
progressive destruction of the exocrine glands,
accompanied by a variety of autoimmune
phenomena. This syndrome can present either
as a primary disorder or as a component of other
autoimmune diseases, such as rheumatoid
arthritis, scleroderma, or systemic lupus ery-
thematosus. 1 Virtually any organ system of the
body can be affected.' The most characteristic
symptoms are keratoconjunctivitis sicca and
xerostomia, resulting from a destructive mono-
nuclear infiltration of the lachrymal and salivary
glands, respectively. Similar mononuclear infil-
trates invading visceral organs can give rise to
such extraglandular manifestations as interstitial
pulmonary fibrosis,2 renal tubular acidosis,3
and Hashimoto's thyroiditis.4
Neurological features are well documented in
primary Sj6gren's syndrome, and peripheral
nervous system disease is reported in 10-32% of
patients with this disorder5 6: mixed poly-
neuropathy confined to the lower extremities
and mononeuritis multiplex are the most com-
monly observed.5 These neuropathies occur
after the diagnosis of Sjogren's syndrome is well
established and they are usually associated with
systemic vasculitis.5 There have recently been
reports of a few patients with primary Sjogren's
syndrome and a new type of sensory neuropathy
due to lymphocytic infiltration of the dorsal root
ganglia.'7-2 In some of these case reports the
clinical setting of this neuropathy was not
completely defined, and the description of
isolated cases prevented identification of the
main clinical and neurophysiological features
that would have been helpful in its diagnosis.
The recognition of this sensory neuropathy,
however, is important because it usually
precedes the diagnosis of Sjogren's syndrome, it
is not associated with systemic vasculitis, and
treatment with corticosteroids may not be
appropriate.
The purpose of this study was to analyse the
clinical, immunological, and electromyographic
findings of a series of five patients with primary
Sjogren's syndrome andpure sensory neuropathy
to determine the most characteristic features
which distinguish this neuropathy from the
more common neuropathies observed in primary
Sjogren's syndrome.
Patients and methods
PATIENTS
The clinical, immunological, and electromyo-
graphic features of five women with pure
sensory neuropathy associated with primary
Sjogren's syndrome, and diagnosed in our
hospital were reviewed. Two of them (patients 4
and 5; table 1) have already been reported."
The median age was 44-4 years (range 28-75
years). All but one patient were first seen
because of the neurological deficit. The onset of
neurological symptoms was asymmetrical,
insidious, and in the arms in all the patients.
Presenting clinical manifestations were numb-
ness, paraesthesias, and difficulty in identifying
objects with the affected hand. The symptoms
slowly progressed over the ensuing years to
affect asymmetrically both upper and lower
extremities. All patients had had long periods
(years) during which the neuropathy seemed to
have stabilised.
All patients had Sjogren's syndrome defined
according to the more commonly used criteria. 3
Keratoconjunctivitis sicca was confirmed by a
positive Schirmer's test and characteristic rose
bengal staining. Xerostomia was confirmed by
an abnormal salivary gland scintigram and a
positive minor salivary gland biopsy specimen.
A work-up to identify an occult malignancy
yielded negative results in all the patients, and
other causes of keratoconjunctivitis sicca,'4
xerostomia, 14 and sensory neuropathy'5 were
excluded. All the patients were prospectively
studied by the authors after sensory neuropathy
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Table 1: Sensory neuropathry and primary Sjogren's syndrome: neurological manifestations
Patient Age/sex Duration of Cranial Sensory disturbances* Deep Muscle
No neuropathy nerves tendon strength(years) Right arm Right leg Left arm Left leg reflexes
1 33/F 6 Adie's pupil Moderate Mild Mild Mild Abolished Normal
2 28/F 6 Adie's pupil Severe Mild Moderate Mild Abolished Normal3 28/F 13 Adie's pupil Moderate Normal Moderate Normal Abolished Normal
4 58/F 7 Trigeminal sensory neuropathy Moderate Mild Mild Mild Abolished Normal5 75/F 5 Trigeminal sensory neuropathy Severe Severe Severe Severe Abolished Normal
*Impairment of joint position and vibratory senses over other sensory modalities in all cases.
Mild=symptoms do not interfere with daily activities; moderate=clinical symptoms cause some limitations in daily activities; severe=extremity practically uselessbecause of the proprioceptive deficit.
had been diagnosed, with a follow up ranging
from two to 13 years.
ELECTROMYOGRAPHIC STUDIES
Needle electromyography (EMG) was performed
in the distal muscles of the hands and feet.
Conventional neuropathic studies of motor and
sensory conduction velocity and compound
action potential amplitude were carried out in
the common peroneal, posterior tibial, sural,
median, and ulnar nerves. Long latency reflex
responses were studied in the arms and legs: H
reflex was tested in soleus muscles, T wave was
tested in soleus and biceps brachii muscles, and
F wave was examined in posterior tibial and
median nerves. Somatosensory evoked cortical
potentials recorded on the scalp were tested
bilaterally by the stimulation of the median
nerve at the wrist and the posterior tibial nerve at
the ankle. Blink reflex was studied in both eyes
by the electrical stimulation of the supraorbital
nerve. The electromyograph used in the study
was an MS8 MEDELEC (Old Woking, Surrey,
England). All tests were performed using routine
techniques'6 and standard equipment and elec-
trodes.
IMMUNOLOGICAL STUDIES
Antinuclear antibodies (ANAs) were deter-
mined by indirect immunofluorescence using
mouse liver as substrate. Rheumatoid factor was
tested by latex fixation (positive titre : 1/40).
Anti-dsDNA antibodies were determined with
Farr's ammonium sulphate precipitation tech-
nique.'7 Antibodies to extractable nuclear anti-
gens (ENA) Ro (SS-A), La (SS-B), Ul-nRNP,
and Sm were detected by counterimmunoelec-
trophoresis using human spleen and calf thymus
extracts.'8 Antimitochondrial and anti-smooth
muscle antibodies were detected by indirect
immunofluorescence using rat kidney and
stomach as substrates.'9 The presence of anti-
bodies against neural antigens was evaluated by
indirect immunofluorescence on frozen sections
of normal human dorsal root ganglia, as
described previously.20 Circulating immune
complexes were detected by Clq binding assay2'
and cryoglobulins by immunoelectrophoresis.22
Complement components (C3 and C4) were
estimated by radial immunodiffusion and CH50
by Lachmann's haemolytic technique.23
Results
Neurological fmdings are summarised in table
1. Pupils were poorly reactive to light and
severely constricted in response to 01% pilo-
carpine (Adie's pupil syndrome) in three
patients; in two the defect was bilateral. Sensory
trigeminal neuropathy was also present in two
patients. All modalities of sensation were
asymmetrically affected. The sensory loss
affecting the vibratory and joint position senses
was disproportionate to the loss of light touch
or pinprick sensations, which were slightly
impaired. Pseudoathetotic movements were
observed in the hand where the deficit was
severe. In the patient with the most severe
neuropathy such movements were present in all
four extremities. Deep tendon reflexes were
absent in all patients. The rest of the neuro-
logical examination yielded normal results.
At the time of the neurological evaluation,
only one patient (No 1) had had Sjogren's
syndrome diagnosed, nine years previously.
Two patients spontaneously complained of
symptoms suggestive of sicca syndrome. In one
(patient No 5) only xerostomia was found at the
time of diagnosis but keratoconjunctivitis sicca
was present one year later. The remaining two
denied the presence of such symptoms, but in
one sicca syndrome was confirmed by Schirmer's
test, rose bengal staining, parotid scintigraphy,
and minor salivary gland biopsy. The other
patient was not specifically evaluated for xero-
stomia and keratoconjunctivitis sicca at the time
of the initial presentation in 1976 but she
developed full-blown sicca syndrome in 1987.
Electromyographic results are summarised in
table 2. The needle biopsy study showed no
signs of denervation. The results of the neuro-
graphic tests of motor nerves were normal. F
wave was present in all nerves examined, but H
Table 2: Sensory neuropathy and primary Sjogren's
syndrome: electrophysiological results
Patient No
1 2 3 4 5
EMG, CMAP, F wave N N N N N
SNAP Right sural A L L A A
Left sural A L N A A
Right median A A A A A
Left median L L A A A
Right ulnar A A A A A
Lcft ulnar A A A A A
SEP Right median L A A A A
Left median L L A A A
Right tibial ND L N A A
Left tibial ND L N A A
H reflex soleus A A A ND A
T wave (soleus, biceps) A A A ND A
BR Right side stimulus D D D ND A
Left side stimulus D N D ND A
N=normal; A=absent; L=low amplitude; D=delayed;
ND=not done; EMG=needle electromyography; CMAP=
compound muscle action potential; SNAP=sensory nerve action
potentials; SEP=somasthetic evoked cortical potentials;
BR=blink reflex.
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reflexes and T waves were absent in all patients.
Most of the neurographic tests of sensory nerves
showed abnormal results, often with absent
responses. Nevertheless, in three patients some
nerves had normal or low amplitude responses,
reflecting asymmetrical clinical disease. Somato-
sensory evoked cortical potentials recorded on
the scalp were not obtained when tested in those
nerves with absent sensory action potentials.
Blink reflexes were absent or delayed in the four
patients examined.
Positive ANA tests were seen in two patients
(Nos 1 and 3) up to a titre of 1/400. Rheumatoid
factor was positive at 1/80 in two patients (Nos 2
and 3). Four patients were positive for Ro (SS-
A) antibodies and three for La (SS-B). All
patients were negative for DNA binding, RNP,
Sm, antimitochondrial, and anti-smooth muscle
antibodies. Circulating immune complexes were
present in patient 1, and cryoglobulins were not
detected. Complement components were normal
in all patients. No patient showed the presence
of specific antibodies against neural antigens.
Nuclear or nucleolar staining of neurones was at
the same titre as that seen in other nuclei,
suggesting that the pattern was due to the
presence of Ro or La antibodies.
To date, the mean duration of our patients'
neuropathy has been 7-4 years (five to 13). All
but one patient remain ambulatory in spite of
the neurological symptoms. In these patients
the principal impairment was usually the pro-
prioceptive defect present in the hand affected
at the onset of the neuropathy. One patient
(No 3) still has the sensory deficit confined to
the arms 13 years after the onset of neuropathy
(table 1). On the other hand, the neuropathy in
patient No 5 took a severe progressive course
two years after the onset of the disease in spite
of treatment with high doses of prednisone
(1 mg/kg daily). Two patients (Nos 1 and 3)
received low doses of prednisone (5 mg daily)
because of sicca syndrome without an apparent
improvement in neuropathy. The other two
patients received no treatment. During follow
up none of the patients developed systemic
vasculitis or lymphoma; patient No 2 developed
Hashimoto's thyroiditis.
Discussion
Unlike previous case reports our study shows
that not only can neuropathy precede the
diagnosis of Siogren's syndrome but it may be
present even when a definite diagnosis of
Sjogren's syndrome cannot be made. Therefore,
appropriate tests must be repeated during follow
up to confirm the diagnosis of Sjogren's syn-
drome. Moreover, the present series shows that
these patients have remarkably similar clinical
and electromyographic features, which differ-
entiate this neuropathy from the more common
neuropathies caused by vasculitic disease of the
peripheral nerve. In all our patients symptoms
started in one hand and slowly progressed to the
other extremities. The neuropathy remained
asymmetrical even years after its onset. All
modalities of sensation were usually affected but
there was always a predominance ofthe vibratory
and joint position senses. Adie's pupil syndrome
was observed in three ofour patients. Autonomic
polyneuropathy has been described in Sjogren's
syndrome associated with sensory9 or sensori-
motor neuropathy.6 Our patients did not com-
plain of other symptoms of autonomic dysfunc-
tion but no studies were done to determine if a
more widespread subclinical autonomic neuro-
pathy was present.
The absence of motor weakness, the presence
of an asymmetrical sensory neuropathy initially
affecting the arms, the fact that the vibratory
and joint position senses syndrome rather than
other modalities of sensation were affected, and
the association with Adie's pupil syndrome or
trigeminal sensory neuropathy are clues to the
clinical diagnosis of this neuropathy. Some of
these features, however, are also described in
patients with Sjogren's syndrome and neuro-
pathies due to necrotising vasculitis in the
peripheral nerve.6 Therefore, a complete elec-
tromyographic evaluation is mandatory to
document the selective sensory dysfunctions.
The results of the electromyographic ex-
amination of our patients were homogeneous
and strongly suggest that the neurological lesion
lies in the neurones of the dorsal root and
Gasserian ganglia. Normal motor nerve and F
wave studies, together with abnormal sensory
nerve and H reflex and T wave studies, indicate
that there is a selective lesion of the sensory
pathways at the level of the neurone itself or at
the peripheral axon. Absence of somatosensory
evoked cortical potentials in nerves with absent
responses to sensory neurographic tests indicates
that the lesion itself should be located at the cell
body. This was only observed in one previous
case report7 and its finding in our five patients
affirms that somatosensory evoked cortical
potentials must be included in the electromyo-
graphic work-up of patients with sensory neuro-
pathies to corroborate the theory that the dorsal
root ganglia are affected.
Interestingly, the clinical and immunological
setting of this sensory neuropathy in Sjogren's
syndrome differs from the more common
sensorimotor neuropathies due to neutrophilic
vasculitis.5 In the latter the neuropathy usually
occurs after the diagnosis of Sjogren's syndrome
is well established, and it is associated with the
presence of rheumatoid factor, immune com-
plexes, and hypocomplementaemia.5 These
immunological abnormalities were not present
in our patients. In previous case reports the
association of the sensory neuropathy with Ro
or La antibodies was unclear. The incidence of
these antibodies is usually increased in patients
with systemic vasculitis and mixed polyneuro-
pathy.5 Four out of five patients, however, had
positive Ro antibodies, even though none had
evidence of systemic vasculitis. Although the
role of the Ro and La antibodies in the
pathogenesis of the sensory neuropathy is
unknown, the high incidence of positive Ro
antibodies suggests that they may be helpful in
the current diagnosis of patients with sensory
neuropathy of unclear origin.
In conclusion, we believe that in patients with
a sensory neuropathy, with the clinical and
electromyographic features reported above, the
diagnosis of Sjogren's syndrome has to be con-
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sidered even if the patient denies the presence
of sicca symptoms. Thus appropriate tests,
including minor salivary gland biopsy and tests
for Ro and La antibodies, have to be under-
taken. If the initial screening is negative the test
should be repeated later because, as seen in
three of our patients, definite Sjogren's syn-
drome was only diagnosed years after the onset
of the neuropathy. In patients with known
Sjogren's syndrome the differentiation of this
neuropathy from those due to necrotising vascu-
litis has important therapeutic implications.
Whereas the latter usually improves with corti-
costeroids5 6 no improvement of the pure
sensory neuropathy has been described with
immunosuppressive drugs. On the other hand,
if the neuropathy is diagnosed when the patient
is minimally disabled, treatment with cortico-
steroids would not be necessary if it is borne in
mind that the course of the neuropathy is
chronic and sometimes benign and that vasculitis
is absent.
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